Intermittent Exercise Among Students

Overview

Evaluate the effectiveness of intermittency anaerobic exercise interventions among the students with high risk of cardiometabolic .

Full Title of Study: “Evaluation the Effectiveness of Intermittent Anaerobic Exercise Among the Students With Cardiometabolic Risk”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Supportive Care
    • Masking: None (Open Label)
  • Study Primary Completion Date: September 2024

Interventions

  • Behavioral: Exercise programme
    • Exercise programme includes 8 anaerobic movements choosen from Tabata. This exercise programme workout is aimed at body fat reduction, and the structure is as follows: 8 anerobic movements in 20 seconds is a set Rest for 10 seconds before another set Finish 4 sets every time, it shall take you 4 minutes Do 4 sets 2 to 3 times a week

Arms, Groups and Cohorts

  • No Intervention: Standard group
    • The participates in this group would provide normal health education of scientific and rational diet.
  • Experimental: Exercise intervention group
    • Besides normal health education of scientific and rational diet,the participates in this group would be suggested to carry out an anaerobic exercise named Tabata.

Clinical Trial Outcome Measures

Primary Measures

  • Abnormal of cardiometabolic risk related index
    • Time Frame: 3th month after enrollment
    • Cardiometabolic risk related index includes fasting blood glucose, blood lipids, blood pressure and abdominal obesity.Cardiometabolic risk related index would be set to 1 as at least 2 indexs mentioned were abnormal while 0 for less than 2.

Secondary Measures

  • Change of Waist-to-height ratio
    • Time Frame: Baseline, 12th months after enrollment
    • Waist-to-height ratio is calculated by the formula :Waist-to-height ratio=waistline (cm)/height(cm). All the participates’ Waist-to-height ratio would be calculated at baseline and 12th months after enrollment. The change would be manifested in the situatuion of the difference.
  • Change of Body Mass Index
    • Time Frame: Baseline, 12th months after enrollment
    • Body Mass Index is calculated by the formula :Body Mass Index=weight(kg)/(height(cm))^2. All the participates’ Body Mass Index would be calculated at baseline and 12th months after enrollment. The change would be manifested in the situatuion of the difference.
  • Change of hipline
    • Time Frame: Baseline, 12th months after enrollment
    • All the participates’ hipline would be measured at baseline and 12th months after enrollment. The change would be manifested in the situatuion of the difference.

Participating in This Clinical Trial

Inclusion Criterias:

  • Male: Waist-to-height ratio≥0.463 – Female: Waist-to-height ratio≥0.469 – Students with cardiometabolic risk factors include elevated BP, dyslipidaemia, elevated fasting blood glucose (FBG) and central obesity. Exclusion Criterias: – Participates with severe disease conditions include cardiac insufficiency, respiratory system relate diseases, immunodeficiency or severe malnutrition, ect – Taking or having taken weight-loss drugs – Participates unsuitable or improper to participate the study

Gender Eligibility: All

Minimum Age: 6 Years

Maximum Age: 18 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Children’s Hospital of Fudan University
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Weili Yan, PhD, Study Chair, Children’s Hospital of Fudan University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.